Pierce Christopher

Number of records: 9
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
07-Sep-21 7:17 PM
View: 
Prelude Therapeutics Inc (PRLD) 02-Sep-21Option Exercise 17,000$12.85$218,450.00453%
3.75K to 20.75K
07-Sep-21 7:17 PM
View: 
Prelude Therapeutics Inc (PRLD) 02-Sep-21Market Option Sale (Planned) 17,000$41.68$708,493.00(82%)
20.75K to 3.75K
30-Apr-21 6:24 PM
View: 
Prelude Therapeutics Inc (PRLD) 29-Apr-21Option Exercise 3,295$1.89$6,227.5588%
3.75K to 7.04K
30-Apr-21 6:24 PM
View: 
Prelude Therapeutics Inc (PRLD) 29-Apr-21Market Option Sale (Planned) 3,295$40.29$132,765.00(47%)
7.04K to 3.75K
15-Apr-21 7:12 PM
View: 
Prelude Therapeutics Inc (PRLD) 08-Apr-21Grant 200$1.89$378.005%
3.75K to 3.95K
15-Apr-21 7:12 PM
View: 
Prelude Therapeutics Inc (PRLD) 08-Apr-21Market Sale (Planned) 200$40.00$8,000.00(5%)
3.95K to 3.75K
09-Apr-21 5:53 PM
View: 
Prelude Therapeutics Inc (PRLD) 07-Apr-21Grant 828$1.89$1,564.9222%
3.75K to 4.58K
09-Apr-21 5:53 PM
View: 
Prelude Therapeutics Inc (PRLD) 07-Apr-21Market Sale (Planned) 828$40.08$33,188.40(18%)
4.58K to 3.75K
29-Sep-20 8:07 PM
View: 
Prelude Therapeutics Inc (PRLD) 29-Sep-20Purchase 3,750$19.00$71,250.00100%
0 to 3.75K